The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types

NCT ID: NCT05054946

Last Updated: 2022-09-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-01

Study Completion Date

2022-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of our study is to compare the effect of laparoscopic ovarian cystectomy on ovarian reserve in terms of different cyst types.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants who will be treated surgically for ovarian cysts will be included in the study. Anti-Mullerian Hormone (AMH) levels of the participants will be investigated before the surgery and 6 months after the surgery. All surgeries will be performed under general anesthesia laparoscopically. After histopathological evaluation, the participants will be divided into three groups; Group 1: Endometrioma, Group 2: Mature cystic teratoma (Dermoid cyst) and Group 3: Serous or mucinous cystadenoma.

A total of fifty-five women will be included in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ovarian Cysts

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Endometrioma

Participants who will have endometrioma after histopathological evaluation.

Group Type ACTIVE_COMPARATOR

Laparoscopic cystectomy

Intervention Type PROCEDURE

All surgeries will be performed under general anesthesia by laparoscopically.

Mature cystic teratoma (dermoid cyst)

Participants who will have mature cystic teratoma (dermoid cyst) after histopathological evaluation.

Group Type ACTIVE_COMPARATOR

Laparoscopic cystectomy

Intervention Type PROCEDURE

All surgeries will be performed under general anesthesia by laparoscopically.

Serous or mucinous cystadenoma

Participants who will have serous or mucinous cystadenoma after histopathological evaluation.

Group Type ACTIVE_COMPARATOR

Laparoscopic cystectomy

Intervention Type PROCEDURE

All surgeries will be performed under general anesthesia by laparoscopically.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laparoscopic cystectomy

All surgeries will be performed under general anesthesia by laparoscopically.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* no ovarian surgery before

Exclusion Criteria

* Endocrinological pathologies
* Suspicion of malignancy in preoperative laboratory and ultrasonographic evaluations
* Detection of malignancy in histopathological examination
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ege University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sabahattin Anıl Arı

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sabahattin Anil Ari, MD

Role: PRINCIPAL_INVESTIGATOR

Ege University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ege University Hospital

Izmir, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17/056

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.